MMJ Files Patent on Part-cannabinoid and Part-non-cannabinoid Treatment for MS
MMJ International Holdings is seeking a patent for a part-cannabinoid and part-non-cannabinoid treatment for multiple sclerosis and other diseases. The company said in a news release that it filed the patent request ahead of Phase 2 clinical trials of the formulation. The therapy was developed by MMJ Bioscience, an affiliate of MMJ International…